Labeling of graphene, graphene oxides, and of their congeners

imaging and biosensing applications of relevance to cancer theranostics

James A. Tyson, David G. Calatayud, Vincenzo Mirabello, Boyang Mao, Sofia I. Pascu

Research output: Contribution to journalArticle

3 Citations (Scopus)
74 Downloads (Pure)

Abstract

The area of biomedical imaging is fast becoming an active focus for the utilization of graphene within a variety of imaging modalities. Graphene can be oxidized to produce a material with a high degree of functionality and has led to its expansion as a platform for the immobilization of fluorescent and radiolabeled molecules. Its large surface area has allowed graphene and its oxides to be modified with a variety of molecules that enhance biocompatibility, selectivity, and therapeutic potential. This chapter highlights recent developments in the use of targeted fluorogenic or radiolabeled graphene materials that can be used to image cancers via fluorescence, positron emission tomography, and single-photon emission computed tomography modalities. Key emphasis is placed on the nanocomposites that are designed to provide additional therapeutic effects. The capacity of these composites to be internalized by cells and tumors is discussed to appreciate the future perspective of graphene and its congeners as therapeutic multimodal imaging agents.

Original languageEnglish
Pages (from-to)397-440
JournalAdvances in Inorganic Chemistry
Volume68
Early online date21 Nov 2015
DOIs
Publication statusPublished - 2016

Fingerprint

Graphite
Oxides
Labeling
Imaging techniques
Single photon emission computed tomography
Molecules
Positron emission tomography
Biocompatibility
Tumors
Nanocomposites
Fluorescence
Composite materials

Keywords

  • Bioimaging
  • Biosensing
  • Cancer theranostic
  • Fluorescence
  • Graphene
  • Graphene oxide
  • Nanomedicine
  • PET
  • Radiolabeling
  • SPECT

Cite this

Labeling of graphene, graphene oxides, and of their congeners : imaging and biosensing applications of relevance to cancer theranostics. / Tyson, James A.; Calatayud, David G.; Mirabello, Vincenzo; Mao, Boyang; Pascu, Sofia I.

In: Advances in Inorganic Chemistry, Vol. 68, 2016, p. 397-440.

Research output: Contribution to journalArticle

@article{56ccd7b1f4734275932ff75b1f437e3a,
title = "Labeling of graphene, graphene oxides, and of their congeners: imaging and biosensing applications of relevance to cancer theranostics",
abstract = "The area of biomedical imaging is fast becoming an active focus for the utilization of graphene within a variety of imaging modalities. Graphene can be oxidized to produce a material with a high degree of functionality and has led to its expansion as a platform for the immobilization of fluorescent and radiolabeled molecules. Its large surface area has allowed graphene and its oxides to be modified with a variety of molecules that enhance biocompatibility, selectivity, and therapeutic potential. This chapter highlights recent developments in the use of targeted fluorogenic or radiolabeled graphene materials that can be used to image cancers via fluorescence, positron emission tomography, and single-photon emission computed tomography modalities. Key emphasis is placed on the nanocomposites that are designed to provide additional therapeutic effects. The capacity of these composites to be internalized by cells and tumors is discussed to appreciate the future perspective of graphene and its congeners as therapeutic multimodal imaging agents.",
keywords = "Bioimaging, Biosensing, Cancer theranostic, Fluorescence, Graphene, Graphene oxide, Nanomedicine, PET, Radiolabeling, SPECT",
author = "Tyson, {James A.} and Calatayud, {David G.} and Vincenzo Mirabello and Boyang Mao and Pascu, {Sofia I.}",
year = "2016",
doi = "10.1016/bs.adioch.2015.09.007",
language = "English",
volume = "68",
pages = "397--440",
journal = "Advances in Inorganic Chemistry",
issn = "0898-8838",
publisher = "Elsevier Academic Press Inc",

}

TY - JOUR

T1 - Labeling of graphene, graphene oxides, and of their congeners

T2 - imaging and biosensing applications of relevance to cancer theranostics

AU - Tyson, James A.

AU - Calatayud, David G.

AU - Mirabello, Vincenzo

AU - Mao, Boyang

AU - Pascu, Sofia I.

PY - 2016

Y1 - 2016

N2 - The area of biomedical imaging is fast becoming an active focus for the utilization of graphene within a variety of imaging modalities. Graphene can be oxidized to produce a material with a high degree of functionality and has led to its expansion as a platform for the immobilization of fluorescent and radiolabeled molecules. Its large surface area has allowed graphene and its oxides to be modified with a variety of molecules that enhance biocompatibility, selectivity, and therapeutic potential. This chapter highlights recent developments in the use of targeted fluorogenic or radiolabeled graphene materials that can be used to image cancers via fluorescence, positron emission tomography, and single-photon emission computed tomography modalities. Key emphasis is placed on the nanocomposites that are designed to provide additional therapeutic effects. The capacity of these composites to be internalized by cells and tumors is discussed to appreciate the future perspective of graphene and its congeners as therapeutic multimodal imaging agents.

AB - The area of biomedical imaging is fast becoming an active focus for the utilization of graphene within a variety of imaging modalities. Graphene can be oxidized to produce a material with a high degree of functionality and has led to its expansion as a platform for the immobilization of fluorescent and radiolabeled molecules. Its large surface area has allowed graphene and its oxides to be modified with a variety of molecules that enhance biocompatibility, selectivity, and therapeutic potential. This chapter highlights recent developments in the use of targeted fluorogenic or radiolabeled graphene materials that can be used to image cancers via fluorescence, positron emission tomography, and single-photon emission computed tomography modalities. Key emphasis is placed on the nanocomposites that are designed to provide additional therapeutic effects. The capacity of these composites to be internalized by cells and tumors is discussed to appreciate the future perspective of graphene and its congeners as therapeutic multimodal imaging agents.

KW - Bioimaging

KW - Biosensing

KW - Cancer theranostic

KW - Fluorescence

KW - Graphene

KW - Graphene oxide

KW - Nanomedicine

KW - PET

KW - Radiolabeling

KW - SPECT

UR - http://www.scopus.com/inward/record.url?scp=84947461332&partnerID=8YFLogxK

UR - http://dx.doi.org/10.1016/bs.adioch.2015.09.007

U2 - 10.1016/bs.adioch.2015.09.007

DO - 10.1016/bs.adioch.2015.09.007

M3 - Article

VL - 68

SP - 397

EP - 440

JO - Advances in Inorganic Chemistry

JF - Advances in Inorganic Chemistry

SN - 0898-8838

ER -